Select Page

The Psychedelic Drugs Market report, at first, has given a brief understanding of the industry through basic overview. This overview includes the market definition, key applications of the product, and the recent manufacturing technology employed for such production. The global Psychedelic Drugs market has been analyzed in detail to gain an understanding of the competitive landscape, key regional status, and recent trends noted in the relevant industry. This analysis also contains the product price margins, along with risk factors that are associated with manufacturers. The report on Psychedelic Drugs market has explored various market dynamics that hold a significant influence during the forecast period of 2020 to 2027.

Request Sample Copy of this Report @

Psychedelic is called as psychedelics, which is class of hallucinogenic drugs including both classic hallucinogens and dissociative drugs which are used recreationally, to enhance the sensory perception, elevate the mood swings, energy level promoting spiritual experiences, and thought process. These drugs have been used experimentally for psychological treatment. 

Market Drivers

Increase in prevalence of depression across the globe is the key driving factor which is expected to boost the global psychedelic drugs market growth. Furthermore, change in lifestyle and requirement for enhanced and better life quality will positively contribute the market growth. Also, increase in research and development activities is expected to propel the market growth during this analysis period. Moreover, increase in dependency on psychedelic drugs for treatment of depression is expected to propel the global psychedelic drugs market growth during this forecast period.

Market Restraints

However, stringent rules and regulations imposed by government to commercialize psychedelic drugs is the major challenging factor which is expected to hinder the global psychedelic drugs market growth. Also, poor efficiency and safety profile of existing intervention will affect the market growth over the forecast period. 

Market Key Players

Various key players are discussed in this report such as AstraZeneca,, COMPASS,, Klarisana, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited,, Dr. Reddy’s Laboratories Ltd,, Pfizer Inc,, Merck & Co., Inc, ,and Lundbeck A/S

Market Taxonomy

By Drug Type

  • Lysergic Acid Diethylamide (LSD)
  • 3,4-Methyl?Enedioxy?Methamphetamine (Ecstasy)
  • Phencyclidine
  • Gamma Hydroxybutyric Acid (GHB)
  • Ketamine
  • Ayahuasca
  • Salvia
  • Psilocybin
  • Others

By Route of Administration

  • Oral
  • Injectable
  • Inhalation

By Distribution Channel

  • Direct Retailers
  • Online Pharmacies
  • Others

By End-User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Browse Full Research Report @

About Us:-

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

Contact Person:-

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A